IM Cannabis Corp.

NasdaqCM:IMCC Stock Report

Market Cap: US$7.8m

IM Cannabis Management

Management criteria checks 3/4

IM Cannabis' CEO is Oren Shuster, appointed in Oct 2019, has a tenure of 5.25 years. total yearly compensation is CA$808.07K, comprised of 58.9% salary and 41.1% bonuses, including company stock and options. directly owns 20.73% of the company’s shares, worth $1.62M. The average tenure of the management team and the board of directors is 3.4 years and 2.3 years respectively.

Key information

Oren Shuster

Chief executive officer

CA$808.1k

Total compensation

CEO salary percentage58.9%
CEO tenure5.3yrs
CEO ownership20.7%
Management average tenure3.4yrs
Board average tenure2.3yrs

Recent management updates

Recent updates

IM Cannabis Shareholder Rafael Gabay raises stake

Sep 08

IM Cannabis GAAP EPS of -C$0.30, revenue of C$23.8M

Aug 15

IM Cannabis receives non-compliance notification from Nasdaq for minimum bid price requirement

Jul 19

cbdMD And IM Cannabis Partner To Sell CBD Products In Israeli Markets

Aug 14

IM Cannabis proposes public offering of securities

May 05

IM Cannabis acquires Israel's largest retail and online pharmacy business from Panaxia

Apr 30

CEO Compensation Analysis

How has Oren Shuster's remuneration changed compared to IM Cannabis's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-CA$13m

Jun 30 2024n/an/a

-CA$14m

Mar 31 2024n/an/a

-CA$15m

Dec 31 2023CA$808kCA$476k

-CA$9m

Sep 30 2023n/an/a

-CA$15m

Jun 30 2023n/an/a

-CA$17m

Mar 31 2023n/an/a

-CA$17m

Dec 31 2022CA$2mCA$506k

-CA$23m

Sep 30 2022n/an/a

-CA$22m

Jun 30 2022n/an/a

-CA$16m

Mar 31 2022n/an/a

-CA$10m

Dec 31 2021CA$2mCA$516k

CA$91k

Sep 30 2021n/an/a

-CA$10m

Jun 30 2021n/an/a

-CA$12m

Mar 31 2021n/an/a

-CA$24m

Dec 31 2020CA$742kCA$424k

-CA$29m

Sep 30 2020n/an/a

-CA$7m

Jun 30 2020n/an/a

-CA$10m

Mar 31 2020n/an/a

-CA$982k

Dec 31 2019CA$2mCA$357k

-CA$7m

Compensation vs Market: Oren's total compensation ($USD559.34K) is about average for companies of similar size in the US market ($USD645.47K).

Compensation vs Earnings: Oren's compensation has been consistent with company performance over the past year.

CEO

Oren Shuster

5.3yrs

Tenure

CA$808,068

Compensation

Mr. Oren Shuster serves as the Co-owner of IMC Ltd. Mr. Shuster serves as Chief Executive Officer and Director of IM Cannabis Corp. since October 11, 2019. Mr. Shuster is a leading figure in the medical ca...

Leadership Team

NamePositionTenureCompensationOwnership
Oren Shuster
CEO & Director5.3yrsCA$808.07k20.73%
$ 1.6m
Uri Birenberg
Chief Financial Officer1.3yrsCA$325.72kno data
Richard Balla
Chief Executive Officer of Adjupharm5yrsCA$293.97k0.029%
$ 2.3k
Anna Taranko
Director Investor & Public Relationsno datano datano data
Michal Nissimov
General Counsel1.8yrsno datano data

3.4yrs

Average Tenure

Experienced Management: IMCC's management team is considered experienced (3.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Oren Shuster
CEO & Director5.3yrsCA$808.07k20.73%
$ 1.6m
Shmulik Arbel
Directorless than a yearno data1.84%
$ 144.3k
Mordechai Marcus
Independent Director2.3yrsCA$96.66kno data
Brian Schinderle
Independent Director3.9yrsCA$135.32kno data
Einat Zakariya
Independent Director2.3yrsCA$93.16k2.06%
$ 161.0k

2.3yrs

Average Tenure

Experienced Board: IMCC's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 08:27
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

IM Cannabis Corp. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Aaron GreyAlliance Global Partners
Jesse PytlakCormark Securities Inc.
John ChuDesjardins Securities Inc.